Indexed keywords
CAFFEINE;
METHYLXANTHINE;
CENTRAL STIMULANT AGENT;
APNEA;
CEREBRAL PALSY;
COGNITIVE DEFECT;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
LUNG DYSPLASIA;
NERVE CELL DIFFERENTIATION;
PREMATURITY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
WEIGHT GAIN;
DEVELOPMENTAL DISORDER;
DRUG EFFECT;
GROWTH, DEVELOPMENT AND AGING;
MORTALITY;
NEWBORN;
NOTE;
RETROLENTAL FIBROPLASIA;
VERY LOW BIRTH WEIGHT;
APNEA;
CAFFEINE;
CENTRAL NERVOUS SYSTEM STIMULANTS;
DEVELOPMENTAL DISABILITIES;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
INFANT, PREMATURE, DISEASES;
INFANT, VERY LOW BIRTH WEIGHT;
RETINOPATHY OF PREMATURITY;
WEIGHT GAIN;
1
0015622210
Apnoeic attacks in newborn treated with aminophylline
Kuzemko JA, Paala J. Apnoeic attacks in newborn treated with aminophylline. Arch Dis Child 1973;48:404-6.
(1973)
Arch Dis Child , vol.48
, pp. 404-406
Kuzemko, J.A.1
Paala, J.2
2
19544373664
Pharmacologic treatment of neonatal apnea
Yaffe SJ, Aranda JV, eds, 3rd ed. Philadelphia: Lippincott Williams & Wilkins
Lopes JM, Aranda JV. Pharmacologic treatment of neonatal apnea. In: Yaffe SJ, Aranda JV, eds. Neonatal and pediatric pharmacology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2005:217-29.
(2005)
Neonatal and pediatric pharmacology , pp. 217-229
Lopes, J.M.1
Aranda, J.V.2
3
0002696406
The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man
Wechsler RL, Kleiss LM, Kety SS. The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man. J Clin Invest 1950;29:28-33.
(1950)
J Clin Invest , vol.29
, pp. 28-33
Wechsler, R.L.1
Kleiss, L.M.2
Kety, S.S.3
4
0021990619
On the mechanism of action of theophylline and caffeine
Fredholm BB. On the mechanism of action of theophylline and caffeine. Acta Med Scand 1985;217:149-53.
(1985)
Acta Med Scand , vol.217
, pp. 149-153
Fredholm, B.B.1
5
0035745978
Mechanisms of cell survival in hypoxia and hypothermia
Boutilier RG. Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 2001;204:3171-81.
(2001)
J Exp Biol , vol.204
, pp. 3171-3181
Boutilier, R.G.1
6
33646681887
Caffeine therapy for apnea of prematurity
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112-21.
(2006)
N Engl J Med , vol.354
, pp. 2112-2121
Schmidt, B.1
Roberts, R.S.2
Davis, P.3
7
35848950709
Long-term effects of caffeine therapy for apnea of prematurity
Idem. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893-902.
(2007)
N Engl J Med , vol.357
, pp. 1893-1902
Schmidt, B.1
Roberts, R.S.2
Davis, P.3
8
0030841377
The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants
Shankaran S, Papile LA, Wright LL, et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 1997;337:466-71.
(1997)
N Engl J Med , vol.337
, pp. 466-471
Shankaran, S.1
Papile, L.A.2
Wright, L.L.3
9
0032537074
A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants
Papile LA, Tyson JE, Stoll BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 1998;338:1112-8.
(1998)
N Engl J Med , vol.338
, pp. 1112-1118
Papile, L.A.1
Tyson, J.E.2
Stoll, B.J.3
10
0016769710
The xanthine treatment of apnea of prematurity
Lucey JF. The xanthine treatment of apnea of prematurity. Pediatrics 1975;55:584-6.
(1975)
Pediatrics , vol.55
, pp. 584-586
Lucey, J.F.1
